Evidence map›Paper›PMID 28620587›Full record

ArticleFrontiers in cellular and infection microbiology2017

A Dual Luciferase Reporter System for

Philip P Adams, Carlos Flores Avile, Mollie W Jewett

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Infectivity GeneInfection and immunity · 2021
    Article
  5. Article
  6. Live Imaging.Current issues in molecular biology · 2021
    Review
  7. Lyme Disease in Humans.Current issues in molecular biology · 2021
    Article
  8. Genetic Manipulation ofCurrent issues in molecular biology · 2021
    Review
  9. Review
  10. Genetic Manipulation of Borrelia Spp.Current topics in microbiology and immunology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Philip P AdamsDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, University of Central Florida College of MedicineOrlando, FL, United States.
Carlos Flores AvileDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, University of Central Florida College of MedicineOrlando, FL, United States.
Mollie W JewettDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, University of Central Florida College of MedicineOrlando, FL, United States.
Florida College · USUniversity of Central Florida · US

Funding

Determination of the genetic basis for B. burgdorferi mammalian infectivityR01AI099094 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI Mollie W Jewett · 2013 to 2026
$4.0M
NIAID NIH HHS R01 AI099094
6 · The paper itself

Abstract

Knowledge of the transcriptional responses of vector-borne pathogens at the vector-pathogen interface is critical for understanding disease transmission.

Indexed as

AnimalsAntigens, BacterialAntigens, SurfaceBacterial Outer Membrane ProteinsBacterial ProteinsBacterial VaccinesBorrelia burgdorferiEnzyme AssaysFemaleFlagellinGene Expression Regulation, BacterialGenes, BacterialGenes, ReporterGenetic VectorsHost-Pathogen InteractionsIxodesAntigens, BacterialAntigens, SurfaceBacterial Outer Membrane ProteinsBacterial ProteinsBacterial VaccinesFlagellinLipoproteinsLuciferasesOspA proteinOspC proteinbioluminescence reporterBorrelia (Borreliella) burgdorferiLyme diseasePhotinus pyralis luciferasePhotinus reniformis luciferasetick-pathogen interactions

Identifiers

PMID28620587
PMCPMC5449462
OpenAlexW2618820367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.